With 1.4 million shares changed hands, the volume of the stock remained lighter than its average volume of 2.1 million shares. During the session, the Healthcare Plans company that operates in wider Healthcare sector, reached to the highest price of $265.0 whereas the lowest price it dropped to was $258.17. The 52-week range on HUM shows that it touched its highest point at $527.18 and its lowest point at $213.31 during that stretch. It currently has a 1-year price target of $286.52. With its current market cap of 31.74 billion, HUM has annualized dividend of $3.54 while the current yield stands at 1.36%. Beta for the stock currently stands at 0.52.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of HUM was down-trending over the past week, with a drop of -0.01%, but this was up by 7.83% over a month. Three-month performance dropped to -26.83% while six-month performance fell -18.67%. The stock lost -46.72% in the past year, while it has lost -43.05% so far this year. A look at the trailing 12-month EPS for HUM yields 11.29 with Next year EPS estimates of 17.72. For the next quarter, that number is -1.93. This implies an EPS growth rate of -38.18% for this year and 9.84% for next year. EPS is expected to grow by 5.00% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 10.46%.
Float and Shares Shorts:
At present, 122.22 million HUM shares are outstanding with a float of 120.11 million shares on hand for trading. On 2024-10-15, short shares totaled 3.78 million, which was 314.00003 higher than short shares on 1726185600. In addition to Ms. Susan Marie Diamond as the firm’s Chief Financial Officer, Mr. Joseph C. Ventura serves as its Chief Legal Officer.
Institutional Ownership:
Through their ownership of 0.96273005 of HUM’s outstanding shares, institutional investors have minority control over the company.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for HUM since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.
